146 related articles for article (PubMed ID: 37855826)
21. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
[TBL] [Abstract][Full Text] [Related]
22. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
Choi KS; Choi SH; Jeong B
Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
[TBL] [Abstract][Full Text] [Related]
23. Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning.
Suchorska B; Schüller U; Biczok A; Lenski M; Albert NL; Giese A; Kreth FW; Ertl-Wagner B; Tonn JC; Ingrisch M
Eur J Cancer; 2019 Jan; 107():15-27. PubMed ID: 30529899
[TBL] [Abstract][Full Text] [Related]
24. MR image phenotypes may add prognostic value to clinical features in IDH wild-type lower-grade gliomas.
Park CJ; Han K; Shin H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Jun; 30(6):3035-3045. PubMed ID: 32060714
[TBL] [Abstract][Full Text] [Related]
25. Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
Han W; Qin L; Bay C; Chen X; Yu KH; Miskin N; Li A; Xu X; Young G
AJNR Am J Neuroradiol; 2020 Jan; 41(1):40-48. PubMed ID: 31857325
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy.
Su X; Yang X; Sun H; Liu Y; Chen N; Li S; Huang Z; Shao H; Zhang S; Gong Q; Yue Q
J Magn Reson Imaging; 2024 Feb; 59(2):628-638. PubMed ID: 37246748
[TBL] [Abstract][Full Text] [Related]
27. Automated glioma grading on conventional MRI images using deep convolutional neural networks.
Zhuge Y; Ning H; Mathen P; Cheng JY; Krauze AV; Camphausen K; Miller RW
Med Phys; 2020 Jul; 47(7):3044-3053. PubMed ID: 32277478
[TBL] [Abstract][Full Text] [Related]
28. Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging.
Liu T; Cheng G; Kang X; Xi Y; Zhu Y; Wang K; Sun C; Ye J; Li P; Yin H
Neuroradiology; 2018 Jul; 60(7):693-702. PubMed ID: 29777252
[TBL] [Abstract][Full Text] [Related]
29. MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting.
Sakai Y; Yang C; Kihira S; Tsankova N; Khan F; Hormigo A; Lai A; Cloughesy T; Nael K
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121211
[TBL] [Abstract][Full Text] [Related]
30. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
[TBL] [Abstract][Full Text] [Related]
31. Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.
Buz-Yalug B; Turhan G; Cetin AI; Dindar SS; Danyeli AE; Yakicier C; Pamir MN; Özduman K; Dincer A; Ozturk-Isik E
Eur J Radiol; 2024 Jan; 170():111257. PubMed ID: 38134710
[TBL] [Abstract][Full Text] [Related]
32. Radiomic profiling for insular diffuse glioma stratification with distinct biologic pathway activities.
Duan W; Wang Z; Ma Z; Zheng H; Li Y; Pei D; Wang M; Qiu Y; Duan M; Yan D; Ji Y; Cheng J; Liu X; Zhang Z; Yan J
Cancer Sci; 2024 Apr; 115(4):1261-1272. PubMed ID: 38279197
[TBL] [Abstract][Full Text] [Related]
33. Deep Learning-based Identification of Brain MRI Sequences Using a Model Trained on Large Multicentric Study Cohorts.
Mahmutoglu MA; Preetha CJ; Meredig H; Tonn JC; Weller M; Wick W; Bendszus M; Brugnara G; Vollmuth P
Radiol Artif Intell; 2024 Jan; 6(1):e230095. PubMed ID: 38166331
[TBL] [Abstract][Full Text] [Related]
34. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
35. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
36. Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI.
Gong E; Pauly JM; Wintermark M; Zaharchuk G
J Magn Reson Imaging; 2018 Aug; 48(2):330-340. PubMed ID: 29437269
[TBL] [Abstract][Full Text] [Related]
37. Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.
Juratli TA; Tummala SS; Riedl A; Daubner D; Hennig S; Penson T; Zolal A; Thiede C; Schackert G; Krex D; Miller JJ; Cahill DP
J Neurooncol; 2019 Jan; 141(2):327-335. PubMed ID: 30536195
[TBL] [Abstract][Full Text] [Related]
38. Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR images.
Jiao T; Li F; Cui Y; Wang X; Li B; Shi F; Xia Y; Zhou Q; Zeng Q
J Magn Reson Imaging; 2023 Nov; 58(5):1624-1635. PubMed ID: 36965182
[TBL] [Abstract][Full Text] [Related]
39. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
40. Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study).
Chelliah A; Wood DA; Canas LS; Shuaib H; Currie S; Fatania K; Frood R; Rowland-Hill C; Thust S; Wastling SJ; Tenant S; McBain C; Foweraker K; Williams M; Wang Q; Roman A; Dragos C; MacDonald M; Lau YH; Linares CA; Bassiouny A; Luis A; Young T; Brock J; Chandy E; Beaumont E; Lam TC; Welsh L; Lewis J; Mathew R; Kerfoot E; Brown R; Beasley D; Glendenning J; Brazil L; Swampillai A; Ashkan K; Ourselin S; Modat M; Booth TC
Neuro Oncol; 2024 Jun; 26(6):1138-1151. PubMed ID: 38285679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
